# Healthcare Realty Trust Incorporated (HR) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $19.12, market value $6.6 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Healthcare Realty Trust Incorporated reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 4.49**. A PEG of 4.49 means the P/E is high relative to expected earnings growth; the price already assumes a lot.
- **Price / sales: 217.0×**. Each dollar of revenue is priced at 217.0×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 1.6×**. The shares trade at 1.6× book value; book value is a meaningful part of the valuation.

## Profitability
- **Net margin: -872.1%**. The company reported a net loss over the last twelve months.
- **Return on equity: -5.3%**. Return on equity is negative because earnings are negative.
- **Return on assets: -0.9%**. Each dollar of assets produces -0.9% of profit.

## Growth
- **Revenue growth (1 yr): 47.3%** (3-yr 27.2%/yr, 5-yr 30.8%/yr). Revenue grew 47.3% over the last year, against 30.8% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 60.8%**. Earnings per share rose 60.8%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.85**. Debt is 0.85 times equity, moderate leverage.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 5.02%** ($0.96 per share, trailing). Healthcare Realty Trust Incorporated yields 5.02%, an income-level yield.
- **Dividend growth (5 yr): -12.5%/yr** (1-yr -11.3%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: hold** (12 analysts). 12 analysts cover Healthcare Realty Trust Incorporated; the consensus is hold, with an average price target of $21.58 (+13% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 13.6%** (YTD 15.7%, 3-mo -2.7%). The shares are up 13.6% over twelve months including dividends.
- **From 52-week high: -13.2%** (17.2% above the low). Trading 13% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 38**. An RSI of 38 is neutral.
- **Beta (1 yr): 0.10** (volatility 20%). Beta of 0.10 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=HR · Page: https://foliofundamentals.com/stocks/hr

Not investment advice.